NCT00396071View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

vildagliptin 100 mg

DRUG

Placebo

matching placebo

Trial Locations (2)

37431

Diabetes Zentrum Bad Lauterberg, Bad Lauterberg im Harz

Unknown

Novartis Pharmaceuticals, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY